Lack of LAT1 and CD98hc Expression on Tumor Cells of Diffuse Glioma: Revisiting the Molecular Basis for Amino Acid PET Imaging and Theranostics [0.03%]
弥漫性胶质瘤肿瘤细胞缺乏LAT1和CD98hc的表达：重新审视氨基酸PET影像学及诊疗的基础分子机制
Jan-Michael Werner,Erwin Tomasich,Maximilian J Mair et al.
Jan-Michael Werner et al.
It is assumed that amino acid PET positivity of gliomas corresponds to tracer uptake by tumor cells via the amino acid transporter heterodimer CD98, consisting of a light (LAT1) and heavy subunit (CD98hc), but correlative studies of human t...
Richard Zimmermann
Richard Zimmermann
First Images on a Next-Generation Extended-Field-of-View Digital Bismuth Germanium Oxide Total-Body PET/CT [0.03%]
新一代大视野数字锗酸铋全身影像PET/CT的初步图像研究
Michael S Hofman,Alicia Corlett,Cameron Pain et al.
Michael S Hofman et al.
First-in-Human [68Ga]Ga-DOTA-Folate PET/CT in a Patient with Ovarian Cancer [0.03%]
卵巢癌患者的[68Ga]Ga-DOTA-Folate PET/CT首次人体研究
Min Tan,Linwei Li,Yan Zhu et al.
Min Tan et al.
Multiorgan Perfusion by PET: Potential Multiple Pathophysiology Interacting with the Heart to Guide Systemic and Cardiac Management [0.03%]
多器官灌注的PET检查：与心脏相互作用的多种病理生理过程指导全身和心脏管理的潜在价值
K Lance Gould,Nils P Johnson
K Lance Gould
The Research Post [0.03%]
科研动态
Jeremie Calais,Johannes Czernin
Jeremie Calais
The Equivalents Are Coming! Developing a Shared Nomenclature for Radiopharmaceutical Therapy of Neuroendocrine Tumors, Prostate Cancer, and Beyond [0.03%]
神经内分泌肿瘤和前列腺癌放射性药物治疗的同源名词术语的发展与应用展望！
Aman Chauhan,Andrew E Hendifar,Ghassan El-Haddad et al.
Aman Chauhan et al.
As radiopharmaceutical therapy (RPT) expands beyond neuroendocrine tumors and prostate cancer, it is important to understand the U.S. Food and Drug Administration (FDA) approval process and to establish a shared vocabulary for effective com...
Performance Evaluation of SmartBrain: A Wearable PET System for Human Brain Imaging [0.03%]
智能脑部成像穿戴式PET系统的性能评估：SmartBrain系统展示
Han Liu,Wenkang Qu,Da Liang et al.
Han Liu et al.
Brain PET is a powerful imaging modality that directly reflects cerebral metabolic activity, making it an essential tool for human brain research. However, conventional brain PET typically requires subjects to remain stationary in a sitting...
Quantifying the Renal Impact of [177Lu]Lu-PSMA-617: A Longitudinal Analysis of Real-World Data from the LUMEN Registry [0.03%]
定量分析[177Lu]Lu-PSMA-617对肾脏的影响：来自LUMEN登记处的现实世界数据纵向分析
Thomas Büttner,Christian Hoffmann,Markus Essler et al.
Thomas Büttner et al.
This study aimed to clarify the renal safety of [177Lu]Lu-PSMA-617 for metastatic castration-resistant prostate cancer (mCRPC), addressing emerging reports of nephrotoxicity. Methods: We retrospectively analyzed patients with mCRPC from the...